L Kalferstova1, K Vilimovska Dedeckova2, M Antuskova1, O Melter1, P Drevinek3. 1. Department of Medical Microbiology, 2(nd) Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. 2. Department of Medical Microbiology, 2(nd) Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic; Department of Paediatrics, 2(nd) Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. 3. Department of Medical Microbiology, 2(nd) Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic; Department of Paediatrics, 2(nd) Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. Electronic address: pavel.drevinek@lfmotol.cuni.cz.
Abstract
BACKGROUND: Pseudomonas aeruginosa is a major cystic fibrosis (CF) pathogen causing chronic respiratory infections and posing a risk for cross-infection between patients with CF. AIM: To propose an algorithm for long-term surveillance of P. aeruginosa and assess its suitability for monitoring the epidemiological situation at a CF centre with approximately 300 patients. METHODS: Over a nine-year period, over 300 P. aeruginosa isolates from 131 infected patients were tested by multi-locus sequence typing (MLST) and/or random amplified polymorphic DNA (RAPD) assay. FINDINGS: MLST analysis led to the identification of 97 different sequence types which were distributed among 17 RAPD-generated (pseudo)clusters. This indicates that the easy-to-perform RAPD assay is only suitable for intra-individual, not interindividual, strain analyses. No epidemic strains were observed. Longitudinal analysis revealed that 110 of the 131 patients were infected with the same strain over the observation period, whereas 21 patients had a strain replacement or a new infection. Chronic infection was found in 99 of the 131 patients, and the remaining 32 patients met the criteria for intermittent infection (as defined by the Leeds criteria). Eighteen of the 32 patients (56%) with intermittent infection were infected with the same strain for up to nine years. CONCLUSION: The strain type only changed in 16% of 131 patients with chronic or intermittent infection. As many as 56% of patients considered to have intermittent infection were actually chronically infected with the same strain for many years.
BACKGROUND:Pseudomonas aeruginosa is a major cystic fibrosis (CF) pathogen causing chronic respiratory infections and posing a risk for cross-infection between patients with CF. AIM: To propose an algorithm for long-term surveillance of P. aeruginosa and assess its suitability for monitoring the epidemiological situation at a CF centre with approximately 300 patients. METHODS: Over a nine-year period, over 300 P. aeruginosa isolates from 131 infected patients were tested by multi-locus sequence typing (MLST) and/or random amplified polymorphic DNA (RAPD) assay. FINDINGS: MLST analysis led to the identification of 97 different sequence types which were distributed among 17 RAPD-generated (pseudo)clusters. This indicates that the easy-to-perform RAPD assay is only suitable for intra-individual, not interindividual, strain analyses. No epidemic strains were observed. Longitudinal analysis revealed that 110 of the 131 patients were infected with the same strain over the observation period, whereas 21 patients had a strain replacement or a new infection. Chronic infection was found in 99 of the 131 patients, and the remaining 32 patients met the criteria for intermittent infection (as defined by the Leeds criteria). Eighteen of the 32 patients (56%) with intermittent infection were infected with the same strain for up to nine years. CONCLUSION: The strain type only changed in 16% of 131 patients with chronic or intermittent infection. As many as 56% of patients considered to have intermittent infection were actually chronically infected with the same strain for many years.
Authors: Zhe Hui Hoo; Elizabeth Coates; Chin Maguire; Hannah Cantrill; Nadia Shafi; Edward F Nash; Angela McGowan; Stephen J Bourke; William G Flight; Thomas V Daniels; Julia A Nightingale; Mark I Allenby; Rachael Curley; Martin J Wildman Journal: Eur J Clin Microbiol Infect Dis Date: 2018-08-18 Impact factor: 3.267
Authors: Zhe Hui Hoo; Frank Peter Edenborough; Rachael Curley; Laura Prtak; Jane Dewar; Mark Ivan Allenby; Julia Anne Nightingale; Martin James Wildman Journal: Eur J Clin Microbiol Infect Dis Date: 2018-01-06 Impact factor: 3.267
Authors: Braj R Singh; M Shoeb; S Sharma; A H Naqvi; Vijai K Gupta; Brahma N Singh Journal: Front Cell Infect Microbiol Date: 2017-03-23 Impact factor: 5.293
Authors: June K Marthin; Jane S Lucas; Mieke Boon; Carmen Casaulta; Suzanne Crowley; Damien M S Destouches; Ernst Eber; Amparo Escribano; Eric Haarman; Claire Hogg; Bernard Maitre; Gemma Marsh; Vendula Martinu; Antonio Moreno-Galdó; Huda Mussaffi; Heymut Omran; Petr Pohunek; Bernhard Rindlisbacher; Phil Robinson; Deborah Snijders; Woolf T Walker; Panayiotis Yiallouros; Helle Krogh Johansen; Kim G Nielsen Journal: ERJ Open Res Date: 2021-08-02